An official website of the United States government
Home
Name
Catumaxomab
Alternate Names
Removab
Abbreviations
None
Category
Chemotherapy
Subcategory
Monoclonal antibody
NSC Number
None
Primary Site
Ovary
Histology
None
Remarks
Used as palliative treatment for malignant ascites from ovarian primaries. It is an orphan drug and has not yet received FDA approval.
Coding
This drug should be coded
